Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies
Si Chen(Institut Pasteur), Ling Chen(Guangzhou Institutes of Biomedicine and Health), Baoqing Sun(First Affiliated Hospital of Guangzhou Medical University), Weiqi Deng(Chinese Academy of Sciences), Linbing Qu(Guangzhou Institutes of Biomedicine and Health), Pingchao Li(Chinese Academy of Sciences), Ping He(Zhejiang University of Science and Technology), Yaohui Zhu(Chinese Academy of Sciences), Hemeng Bu(Chinese Academy of Sciences), Wenming Liu(Changzhou University), Hengchun Li(Chinese Academy of Sciences), Xinwen Chen(Guangzhou Experimental Station), Qian Wang(Army Medical University), Feng Li(Guangzhou Eighth People's Hospital), Zhengyuan Zhang(Ruijin Hospital), Zhilong Chen(Xiamen University), Zijian Liu(Chinese Academy of Sciences), Nanshan Zhong(State Key Laboratory of Respiratory Disease), Li Yin(Chinese Academy of Sciences), Linjing Shi(Chinese Academy of Sciences), Lishan Ning(Chinese Academy of Sciences), Liqiang Feng(Third People's Hospital of Hangzhou), Yijun Deng, Jielin Tang(Guangzhou Experimental Station), Qi Yang(Gansu Agricultural University), Xiaoli Xiong(Henan University of Technology)
Cited by 27
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|655